A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Alpha-9 Oncology USA Inc.
Alpha-9 Oncology USA Inc.
MonTa Biosciences ApS
Aura Biosciences
Aura Biosciences
Immatics US, Inc.
Replimune Inc.
IDEAYA Biosciences
IDEAYA Biosciences
OncoNano Medicine, Inc.
Linnaeus Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Novelwise Pharmaceutical Corporation
Modulation Therapeutics, Inc.
Novelty Nobility, Inc.
Aura Biosciences